Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delancey Street Partners is a private, independent, industry-focused investment bank that advises high-growth and middle-market private and public companies. The firm provides sell-side and buy-side M&A advisory, growth capital financings, recapitalizations, and strategic evaluation services. It operates across several sectors, including healthcare, business services and technology, industrial and industrial technology, and infrastructure. Within healthcare, the firm focuses on areas such as outsourced pharmaceutical services, life science tools, healthcare staffing, revenue cycle management, and other healthcare services. Delancey Street Partners is not a drug developer, biotech, pharma company, CRO, or CDMO; it is a financial advisor serving companies in those sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delancey Street Partners.